Rare Classroom: Hyponatremia
source: shutterstock

Rare Classroom: Hyponatremia

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Continue Reading Rare Classroom: Hyponatremia
“Long COVID” Has Brought New Attention to Myalgic Encephalomyelitis
source: pixabay.com

“Long COVID” Has Brought New Attention to Myalgic Encephalomyelitis

According to a story from PR Newswire, Solve M.E. is gathering virtually on Capitol Hill for its 5th Annual Advocacy Week, starting April 19th. A record number of people are…

Continue Reading “Long COVID” Has Brought New Attention to Myalgic Encephalomyelitis
Study Finds Thrombosis May be the First Sign of Granulomatosis with Polyangiitis
source: pixabay.com

Study Finds Thrombosis May be the First Sign of Granulomatosis with Polyangiitis

A recent study has found that thrombosis may be the first manifestation of granulomatosis with polyangiitis disease in children following the very first report of its presentation in a 13…

Continue Reading Study Finds Thrombosis May be the First Sign of Granulomatosis with Polyangiitis
Study Finds Consistent Exercise Can Have Positive Physical and Mental Health Benefits for Pulmonary Hypertension Patients
source: pixabay.com

Study Finds Consistent Exercise Can Have Positive Physical and Mental Health Benefits for Pulmonary Hypertension Patients

A recent study has found that aerobic and strength training exercise programs can have a long term effect on physical functioning for patients with pulmonary hypertension (PH). PH is a…

Continue Reading Study Finds Consistent Exercise Can Have Positive Physical and Mental Health Benefits for Pulmonary Hypertension Patients
Researchers May Have Found a More Effective Pompe Disease Treatment
Source: https://pixabay.com/en/hospital-infusion-drip-antibiotic-834152/

Researchers May Have Found a More Effective Pompe Disease Treatment

According to News Medical, researchers from the University of Cincinnati presented findings on a potentially new and effective treatment option for Pompe disease at the virtual American Academy of Neurology…

Continue Reading Researchers May Have Found a More Effective Pompe Disease Treatment
Investigative Therapy for Duchenne Muscular Dystrophy is in a Phase 3 Clinical Trial
Source: Pixabay

Investigative Therapy for Duchenne Muscular Dystrophy is in a Phase 3 Clinical Trial

FibroGen has just announced that their investigative therapy pamrevlumab, for Duchenne muscular dystrophy (DMD), has received Rare Pediatric Disease designation from the FDA. The treatment already was given Fast Track…

Continue Reading Investigative Therapy for Duchenne Muscular Dystrophy is in a Phase 3 Clinical Trial
April 23 is International FOP Awareness Day: Spreading Rare Disease Awareness
source: pixabay.com

April 23 is International FOP Awareness Day: Spreading Rare Disease Awareness

The International Fibrodysplasia Ossificans Progressiva Association (IFOPA) is gearing up to recognize International FOP Awareness Day this year on April 23, 2021. The event is meant to help spread awareness…

Continue Reading April 23 is International FOP Awareness Day: Spreading Rare Disease Awareness
Creating Compassionate, Respected Online Rare Disease Communities: 7 Tips For Success
source: pixabay.com

Creating Compassionate, Respected Online Rare Disease Communities: 7 Tips For Success

In a previous article, I talked about the importance of patient-led advocacy groups and how they can positively impact how a rare diagnosis is received and understood by patients.  Do…

Continue Reading Creating Compassionate, Respected Online Rare Disease Communities: 7 Tips For Success
Results from Phase 1 HATTR Amyloidosis Trial Presented at Recent Meeting
source: pixabay.com

Results from Phase 1 HATTR Amyloidosis Trial Presented at Recent Meeting

According to a story from globenewswire.com, the clinical company Prothena Corporation plc recently presented encouraging results from its phase 1 clinical trial. This trial was evaluating its investigational product candidate…

Continue Reading Results from Phase 1 HATTR Amyloidosis Trial Presented at Recent Meeting